Incident malignancies among older long-term breast cancer survivors and an age-matched and site-matched nonbreast cancer comparison group over 10 years of follow-up

Cancer

Volumn 119, Issue 8, 2013, Pages 1478-1485

  Clough Gorr, Kerri M ^a,b,c   Thwin, Soe Soe ^b,d   Bosco, Jaclyn L F ^b,e   Silliman, Rebecca A ^b,f   Buist, Diana S M ^g   Pawloski, Pamala A ^h   Quinn, Virginia P ⁱ   Prout, Marianne N ^f  

^a UNIVERSITY OF BERN   (Switzerland)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c National Institute for Cancer Epidemiology and Registration   (Switzerland)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f BOSTON UNIVERSITY   (United States)

^g GROUP HEALTH RESEARCH INSTITUTE   (United States)

^h HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

ⁱ Research and Evaluation   (United States)

Author keywords

breast cancer; breast cancer survivors; incident malignancies; malignancy; multiple primary malignancies; older women; survivors

Indexed keywords

AGED; AGING; ARTICLE; BODY MASS; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVOR; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; GYNECOLOGIC CANCER; HUMAN; INCIDENT MALIGNANCY; LEUKEMIA; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL TIME;

AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; RISK FACTORS; SURVIVORS; UNITED STATES;

EID: 84876014328     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27914     Document Type: Article

References (28)

1. American Cancer Society. Breast Cancer Facts & Figures. Atlanta, GA: American Cancer Society; 2012.
2. Lash TL, Silliman RA,. Re: prevalence of cancer. J Natl Cancer Inst. 1998; 90: 399-400.
3. Reis L, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2005. In: Edwards BK, ed. Bethesda, MD: National Cancer Institute; 2008. Available at: http://seer.cancer.gov/csr/1975-2005/. [Accessed June 15, 2012.]
4. Hayat MJ, Howlader N, Reichman ME, Edwards BK,. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. 2007; 12: 20-37.
5. Mariotto AB, Rowland JH, Ries LA, Scoppa S, Feuer EJ,. Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev. 2007; 16: 566-571.
6. Travis LB,. Therapy-associated solid tumors. Acta Oncol. 2002; 41: 323-333.
7. Travis LB, Rabkin CS, Brown LM, et al. Cancer survivorship-genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst. 2006; 98: 15-25.
8. Boice JD Jr, Harvey EB, Blettner M, Stovall M, Flannery JT,. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med. 1992; 326: 781-785.
9. Gotay CC, Ransom S, Pagano IS,. Quality of life in survivors of multiple primary cancers compared with cancer survivor controls. Cancer. 2007; 110: 2101-2109.
10. Hemminki K, Ji J, Forsti A,. Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk. Cancer Res. 2007; 67: 868-870.
11. Kirova YM, Gambotti L, De Rycke Y, Vilcoq JR, Asselain B, Fourquet A,. Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review. Int J Radiat Oncol Biol Phys. 2007; 68: 359-363.
12. Ng AK, Travis LB,. Second primary cancers: an overview. Hematol Oncol Clin North Am. 2008; 22: 271-289, vii.
13. Storm HH, Andersson M, Boice JD Jr, et al. Adjuvant radiotherapy and risk of contralateral breast cancer. J Natl Cancer Inst. 1992; 84: 1245-1250.
14. Avila CC, Quinn VP, Geiger AM, Kerby TJ, St Charles M, Clough-Gorr KM,. Webinar training: an acceptable, feasible and effective approach for multi-site medical record abstraction: the BOWII experience [serial online]. BMC Res Notes. 2011; 4: 430.
15. National Cancer Institute; Surveillance, Epidemiology, and End Results (SEER) Program. SEER Program Coding and Staging Manual, 2007. In: Johnson CH, Adamo M, eds. Bethesda, MD: National Cancer Institute; 2007. Available at: http://seer.cancer.gov/manuals/2007/SPCSM-07-maindoc.pdf. [Accessed June 15, 2012.]
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373-383.
17. Rosthoj S, Andersen PK, Abildstrom SZ,. SAS macros for estimation of the cumulative incidence functions based on a Cox regression model for competing risks survival data. Comput Methods Programs Biomed. 2004; 74: 69-75.
18. Pintilie M,. Competing Risks: A Practical Perspective. West Sussex, United Kingdom: John Wiley & Sons, Ltd.; 2006.
19. Greenland S,. Chapter 21. Introduction to regression modeling. In:, Rothman KJ, Greenland S, Lash TL, eds. Modern Epidemiology. 3rd ed. Philadelphia, PA: Lippincott-Raven; 1998: 401-434.
20. SAS Institute, Inc. Statistical Analysis System (SAS) version 9.2 [software package]. Cary, NC: SAS Institute, Inc.; 2006.
21. American Cancer Society. Breast Cancer Facts & Figures. Atlanta, GA: American Cancer Society; 2010.
22. Brown LM, Chen BE, Pfeiffer RM, et al. Risk of second non-hematological malignancies among 376,825 breast cancer survivors. Breast Cancer Res Treat. 2007; 106: 439-451.
23. Curtis RE, Freedman DM, Ron E, et al, eds. New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000. Bethesda, MD: National Cancer Institute; 2006.
24. Schoen RE, Weissfeld JL, Kuller LH,. Are women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer? Am J Gastroenterol. 1994; 89: 835-842.
25. Newschaffer CJ, Topham A, Herzberg T, Weiner S, Weinberg DS,. Risk of colorectal cancer after breast cancer. Lancet. 2001; 357: 837-840.
26. Eisen GM, Sandler RS,. Are women with breast cancer more likely to develop colorectal cancer? Critical review and meta-analysis. J Clin Gastroenterol. 1994; 19: 57-63.
27. Srinivasan R, Yang YX, Rubin SC, Morgan MA, Lewis JD,. Women with a prior diagnosis of breast cancer are not at an increased risk for subsequent colorectal cancer. Am J Gastroenterol. 2005; 100: 2759-2764.
28. Rutqvist LE, Johansson H, Signomklao T, Johansson U, Fornander T, Wilking N,. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. J Natl Cancer Inst. 1995; 87: 645-651.